NDAC to gain pediatric pain expertise, retain dermatological specialist with new members.
This article was originally published in The Tan Sheet
Executive Summary
NDAC GAINS PEDIATRIC PAIN EXPERTISE, RETAINS DERMATOLOGICAL SPECIALIST with two of the four experts FDA has invited to join the Nonprescription Drugs Advisory Committee this summer. Nominee Patricia McGrath, PhD, director of the Child Health Research Institute in Ontario, has researched and written extensively on the physiology and psychology of pain in children. Outgoing panel member and NIH dermatologist Maria Chanco Turner is expected to be replaced by Lynn McKinley-Grant, MD, chief of the Dermatology Medical Services section of the Veterans Affairs Medical Hospital. In addition, Paul Roberts, MD, will remain with NDAC as the designated industry representative following his renomination.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning